Search
for
Sort by
Research 181–210 of 1000+
- A Cross-Sectional Analysis of Psychological and Dermatologic Manifestations Post-February 6 Earthquakes in Dermatology Patients
- Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Eflúvio Telógeno pós-COVID: uma revisão integrativa
- Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- EVALUATION OF ASSOCIATION OF ANTHROPOMETRIC INDICES WITH STRESS RESPONSE IN PCOS POPULATION
- Hypothalamic-pituitary-adrenal axis, hair, and sebum: Stress-mediated dermatologic disasters of the pandemic era
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
- JCD — Editorial Commentary, May, 2021
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Autoamputation in a 45-Year-Old Female with Systemic Lupus Erythematosus Overlap with Systemic Sclerosis: A Case Report
- Hair loss in women
- Hair transplantation: A brief review
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- The JAK/STAT signaling pathway: from bench to clinic
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Investigating self-reported hair loss following covid-19 infection in the Iraqi population